Oct 9, 2015

Boom Or Bust: Why Does Cancer Immunotherapy Have Such Mixed Results?

Posted by in categories: biotech/medical, innovation

Treating cancer by boosting the immune system has been hailed as a major breakthrough in cancer treatment. It may melt away tumours in some patients but it isn’t always effective, and can even be dangerous.

The FDA approved two new immunotherapy drugs in 2015, and over half current cancer trials now involve immunotherapy. The field has the potential to completely change cancer treatment, but it’s still early days.

Read more

Comments are closed.